Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mannkind
Pharma
FDA approves Corstasis' nasal spray as treatment for edema
The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy
Sep 15, 2025 3:33pm
MannKind makes $360M M&A play for scPharmaceuticals
Aug 25, 2025 11:30am
Mannkind wraps up phase 1 trial of inhaled lung infection asset
Sep 6, 2022 9:35am
United scores hard-earned FDA approval for inhaled Tyvaso
May 24, 2022 9:38am
MannKind inks $10M deal to buy Zealand’s insulin delivery tech
May 17, 2022 8:05am
RLS bags $10M to trial dry powder inhaled CBD in anxiety
Apr 12, 2022 8:00am
